ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.
Ann Oncol
; 34(10): 934-945, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37406812
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
Database:
MEDLINE
Main subject:
Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Ann Oncol
Year:
2023
Document type:
Article